Peritoneal dialysis-associated peritonitis with Elizabethkingia miricola

Masnun Kayes; Daniela Potter; Jeffrey Wong; Tim Spicer

doi:10.1136/bcr-2023-255491

Peritoneal dialysis-associated peritonitis with Elizabethkingia miricola

BMJ Case Rep. 2023 Dec 11;16(12):e255491. doi: 10.1136/bcr-2023-255491.

Authors

Masnun Kayes^{1

2}, Daniela Potter^{3

2}, Jeffrey Wong^{3

2}, Tim Spicer^{3

2}

Affiliations

¹ School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia masnun.kayes@gmail.com.
² Renal Medicine, Liverpool Hospital, Liverpool, New South Wales, Australia.
³ School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.

PMID: 38081734
PMCID: PMC10729244 (available on 2025-12-10)
DOI: 10.1136/bcr-2023-255491

Abstract

Peritoneal dialysis (PD)-associated peritonitis is linked to increased mortality rates and transfer to haemodialysis or PD discontinuation. Rare and emerging pathogens can pose challenges in management. We present the first case of PD peritonitis caused by Elizabethkingia miricola through direct contamination, which was successfully treated with intraperitoneal and oral antibiotics.

Keywords: Dialysis; Infectious diseases; Renal medicine.

Publication types

Case Reports

MeSH terms

Anti-Bacterial Agents / therapeutic use
Flavobacteriaceae*
Humans
Peritoneal Dialysis* / adverse effects
Peritonitis* / drug therapy
Peritonitis* / etiology

Substances

Anti-Bacterial Agents

Supplementary concepts

Elizabethkingia miricola